{"gene":"CDC50B","run_date":"2026-06-09T22:57:18","timeline":{"discoveries":[{"year":2008,"finding":"CDC50B acts as an accessory protein required for ER exit and plasma membrane trafficking of the P4-ATPase ATP8B1; coexpression of CDC50B with ATP8B1 in CHO cells relocalizes ATP8B1 from the ER to the plasma membrane and increases fluorescently labeled phosphatidylserine translocation by 250–500%, while also reducing phosphatidylserine exposure on the outer leaflet of the plasma membrane by ~17–25%.","method":"Heterologous coexpression in CHO cells, fluorescent lipid translocation assay, annexin V-based phosphatidylserine exposure assay, subcellular localization imaging","journal":"Hepatology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal functional rescue in cells with two orthogonal readouts (lipid translocation assay and PS-exposure assay), single lab but multiple methods","pmids":["17948906"],"is_preprint":false},{"year":2010,"finding":"CDC50B interacts with (co-immunoprecipitates) the class 1 P4-ATPases ATP8B1 and ATP8B2 but not with ATP8B4, ATP8A1, or ATP8A2; CDC50B coexpression shifts ATP8B1 from the ER to the plasma membrane; interactions between CDC50 proteins and P4-ATPases are required for ER exit and stability of both subunits; subcellular localization of the complex is determined by the P4-ATPase subunit, not by CDC50B.","method":"Co-immunoprecipitation, subcellular localization imaging in heterologous expression system","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — co-IP with multiple P4-ATPases tested for specificity, plus localization experiments, single lab with multiple orthogonal methods","pmids":["20947505"],"is_preprint":false},{"year":2011,"finding":"CDC50B does NOT associate with ATP8A2 in HEK293T cells and does not support phosphatidylserine flippase activity of ATP8A2; chimeric CDC50 proteins replacing domains of CDC50B with CDC50A domains showed that both transmembrane and exocytoplasmic domains of CDC50A (not CDC50B) are required for a functional ATP8A2 complex, indicating CDC50B is insufficient as a beta-subunit for ATP8A2.","method":"Co-immunoprecipitation in HEK293T cells, chimeric protein domain-swap mutagenesis, lipid transport assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — negative result for CDC50B–ATP8A2 interaction established by co-IP and confirmed by chimera mutagenesis plus functional lipid transport assay, single lab with multiple orthogonal methods","pmids":["21454556"],"is_preprint":false},{"year":2004,"finding":"CDC50B (TMEM30B) was identified in silico as a two-transmembrane-spanning protein with one extracellular loop, conserved topology with yeast Cdc50p/Lem3p homologs, and predicted to function as a component of phospholipid translocators; mapped to human chromosome 14q23.1.","method":"Bioinformatics/in silico sequence and topology analysis","journal":"Oncology reports","confidence":"Low","confidence_rationale":"Tier 4 / Weak — computational prediction only, no experimental validation in this paper","pmids":["15375526"],"is_preprint":false},{"year":2022,"finding":"Cryo-EM structures of ATP8B1 complexed with both CDC50A and CDC50B reveal that CDC50B can serve as an auxiliary noncatalytic partner of ATP8B1 and that the complex adopts an autoinhibited state that is released upon substrate (phospholipid) binding; bile acids can facilitate release of this autoinhibition.","method":"Cryo-EM structure determination, substrate-binding analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — cryo-EM structural determination of the ATP8B1–CDC50B complex with mechanistic interpretation of autoinhibition release, single study but Tier 1 method","pmids":["35349344"],"is_preprint":false},{"year":2023,"finding":"Experimental validation in HEK293 and HK-2 cells confirmed that TMEM30B (CDC50B) is a membrane-bound protein localized to the endoplasmic reticulum, with both N- and C-termini facing the cytoplasm.","method":"Overexpression studies, subcellular fractionation, topology/localization assays in HEK293 and HK-2 cells","journal":"American journal of cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct localization experiment with topology determination, single lab, single study","pmids":["37293153"],"is_preprint":false},{"year":2024,"finding":"TMEM30B is a direct transcriptional target of CREB3L1 in odontoblasts; deletion of Tmem30b in mouse dental papilla cells (mDPCs) impaired odontoblastic differentiation, protein synthesis, and protein secretion; overexpression of TMEM30B in CREB3L1-deficient mDPCs partially rescued extracellular protein secretion.","method":"ATAC-seq, RNA-seq, Tmem30b knockout in mDPCs, rescue by TMEM30B overexpression, in vivo Creb3l1 conditional knockout","journal":"International journal of oral science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with defined cellular phenotypes and partial rescue experiment, single lab with multiple orthogonal methods (ATAC-seq, RNA-seq, functional assays)","pmids":["39384739"],"is_preprint":false},{"year":2026,"finding":"In cochlear outer hair cells (OHCs), Tmem30b partners with Atp8b1 to regulate phospholipid asymmetry; Tmem30b-/- mice show early-onset hearing loss with OHC stereocilia disorganization starting at P7 (coinciding with Tmem30b localization to stereocilia); AAV-mediated delivery of Tmem30b rescues stereocilia defects in both Tmem30b-/- and Atp8b1-/- mice; Tmem30b translocates from the nuclear membrane at P5 to stereocilia and cuticular plate during maturation.","method":"Tmem30b knockout mouse, live imaging/immunofluorescence for localization, AAV rescue experiment, auditory function testing (ABR), co-localization studies","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with defined phenotype, AAV rescue (including cross-rescue in Atp8b1-/- mice), dynamic localization tracking, multiple orthogonal methods in single study","pmids":["42054370"],"is_preprint":false},{"year":2026,"finding":"ATP8B1 and TMEM30B are selectively expressed in OHCs, enriched in stereocilia, and upregulated following onset of mechanoelectrical transduction (MET) and hearing; loss of TMEM30B results in elevated ABR thresholds, phosphatidylserine externalization, and rapid hair-cell degeneration, establishing TMEM30B as required for membrane lipid asymmetry maintenance in OHCs.","method":"Conditional knockout mouse, auditory brainstem response (ABR) measurement, immunofluorescence/localization, phosphatidylserine externalization assay","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — preprint, loss-of-function with multiple functional readouts, single lab","pmids":["41726979"],"is_preprint":true}],"current_model":"CDC50B (TMEM30B) is a two-transmembrane ER-resident chaperone/beta-subunit that physically associates with select class 1 P4-ATPases (notably ATP8B1 and ATP8B2 but not ATP8A2), facilitating their ER exit, trafficking to the plasma membrane, and phosphatidylserine flippase activity; cryo-EM structures show CDC50B binds ATP8B1 as a noncatalytic auxiliary subunit stabilizing an autoinhibited state that is released upon lipid substrate binding; in cochlear outer hair cells, the Tmem30b–Atp8b1 complex localizes to stereocilia and the cuticular plate to maintain phospholipid asymmetry, and its loss causes stereocilia disorganization and hearing loss; CDC50B also plays a role in protein secretion during odontoblast differentiation downstream of CREB3L1."},"narrative":{"mechanistic_narrative":"CDC50B (TMEM30B) is a two-transmembrane, endoplasmic reticulum-resident accessory subunit that selectively partners with class 1 P4-ATPase phospholipid flippases to enforce membrane lipid asymmetry [PMID:17948906, PMID:20947505, PMID:37293153]. It physically associates with ATP8B1 and ATP8B2 — but not ATP8B4, ATP8A1, or ATP8A2 — and this interaction is mutually required for ER exit and stability of both partners, with the P4-ATPase subunit dictating the final localization of the complex [PMID:20947505]. Functionally, CDC50B coexpression relocalizes ATP8B1 from the ER to the plasma membrane and markedly increases inward phosphatidylserine translocation while reducing outer-leaflet PS exposure [PMID:17948906]. Cryo-EM of the ATP8B1–CDC50B complex shows CDC50B serving as a noncatalytic auxiliary partner that stabilizes an autoinhibited state released upon phospholipid substrate binding, with bile acids facilitating this release [PMID:35349344]. The complex has a defined physiological role in cochlear outer hair cells, where the Tmem30b–Atp8b1 pair localizes to stereocilia and the cuticular plate to maintain phospholipid asymmetry; loss of Tmem30b causes phosphatidylserine externalization, stereocilia disorganization, hair-cell degeneration, and early-onset hearing loss that is reversible by AAV-mediated Tmem30b delivery [PMID:42054370]. Beyond its flippase chaperone role, CDC50B is a direct transcriptional target of CREB3L1 and supports protein synthesis and secretion during odontoblast differentiation [PMID:39384739].","teleology":[{"year":2008,"claim":"Established that CDC50B is not merely a sequence homolog but a functional accessory protein that traffics a P4-ATPase out of the ER and enables its flippase activity, defining its core role.","evidence":"Heterologous coexpression in CHO cells with fluorescent lipid translocation and annexin V PS-exposure assays","pmids":["17948906"],"confidence":"High","gaps":["Did not test specificity against other P4-ATPases","Mechanism of how CDC50B promotes ER exit not resolved"]},{"year":2010,"claim":"Defined the partner selectivity and mutual dependence of the interaction, showing CDC50B binds ATP8B1/ATP8B2 specifically and that the P4-ATPase, not CDC50B, sets complex localization.","evidence":"Co-IP with a panel of P4-ATPases and subcellular localization imaging in heterologous cells","pmids":["20947505"],"confidence":"High","gaps":["Did not establish stoichiometry or structural basis of selectivity","Endogenous interactions not confirmed"]},{"year":2011,"claim":"Delimited CDC50B function by showing it is insufficient as a beta-subunit for ATP8A2, with chimera swaps pinpointing CDC50A's transmembrane and exocytoplasmic domains as the determinants of that incompatibility.","evidence":"Co-IP and chimeric domain-swap mutagenesis with lipid transport assay in HEK293T cells","pmids":["21454556"],"confidence":"High","gaps":["Why CDC50B cannot substitute structurally remained undefined at the time","Did not address physiological tissue-specific pairing"]},{"year":2022,"claim":"Provided structural mechanism, showing CDC50B acts as a noncatalytic auxiliary subunit stabilizing an autoinhibited ATP8B1 state that is relieved by substrate and bile acids.","evidence":"Cryo-EM structure determination of ATP8B1 with CDC50A and CDC50B plus substrate-binding analysis","pmids":["35349344"],"confidence":"High","gaps":["Functional consequence of autoinhibition release in cells not quantified","Whether CDC50B vs CDC50A confer distinct regulatory properties not resolved"]},{"year":2023,"claim":"Confirmed CDC50B is an ER-localized membrane protein with both termini cytoplasmic, anchoring its topology and subcellular compartment experimentally.","evidence":"Overexpression, subcellular fractionation, and topology assays in HEK293 and HK-2 cells","pmids":["37293153"],"confidence":"Medium","gaps":["Single-lab topology determination","ER residence under endogenous conditions not shown"]},{"year":2024,"claim":"Extended CDC50B function beyond flippase chaperoning by placing it in a CREB3L1 secretory program, where it supports protein synthesis and secretion during odontoblast differentiation.","evidence":"ATAC-seq, RNA-seq, Tmem30b knockout in mDPCs, and overexpression rescue in CREB3L1-deficient cells","pmids":["39384739"],"confidence":"Medium","gaps":["Molecular link between flippase activity and secretion not established","Rescue was only partial"]},{"year":2026,"claim":"Demonstrated an in vivo physiological requirement: the Tmem30b–Atp8b1 complex maintains stereocilia lipid asymmetry, and its loss causes hearing loss rescuable by gene delivery, including cross-rescue of Atp8b1 mutants.","evidence":"Tmem30b knockout mice, dynamic localization imaging, AAV rescue, and ABR auditory testing","pmids":["42054370"],"confidence":"High","gaps":["Mechanism linking lipid asymmetry loss to stereocilia disorganization not detailed","Relevance to human hearing loss not directly tested"]},{"year":2026,"claim":"Reinforced the OHC role by tying TMEM30B/ATP8B1 expression to mechanoelectrical transduction onset and showing loss causes PS externalization and rapid hair-cell degeneration.","evidence":"Conditional knockout mice, ABR, immunofluorescence, and PS-externalization assays (preprint)","pmids":["41726979"],"confidence":"Medium","gaps":["Preprint, not peer-reviewed","Overlaps with the same year's published study; independent confirmation pending"]},{"year":null,"claim":"How CDC50B selectivity for ATP8B1/ATP8B2, its ER-exit chaperone role, and its CREB3L1-linked secretory function are mechanistically integrated, and whether human CDC50B mutations cause disease, remain open.","evidence":"","pmids":[],"confidence":"Low","gaps":["No human disease-causing mutation reported in the corpus","Connection between flippase activity and protein secretion unresolved","Tissue-specific partner choice mechanism unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,4]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,1]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[4]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[0,1,5]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,1,7]}],"pathway":[],"complexes":["ATP8B1–CDC50B P4-ATPase flippase complex"],"partners":["ATP8B1","ATP8B2","CREB3L1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q3MIR4","full_name":"Cell cycle control protein 50B","aliases":["P4-ATPase flippase complex beta subunit TMEM30B","Transmembrane protein 30B"],"length_aa":351,"mass_kda":38.9,"function":"Accessory component of a P4-ATPase flippase complex which catalyzes the hydrolysis of ATP coupled to the transport of aminophospholipids from the outer to the inner leaflet of various membranes and ensures the maintenance of asymmetric distribution of phospholipids. Phospholipid translocation also seems to be implicated in vesicle formation and in uptake of lipid signaling molecules. The beta subunit may assist in binding of the phospholipid substrate (Probable). Can mediate the export of alpha subunits ATP8A1, ATP8B1, ATP8B2 and ATP8B4 from the ER to the plasma membrane","subcellular_location":"Cell membrane; Endoplasmic reticulum membrane","url":"https://www.uniprot.org/uniprotkb/Q3MIR4/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"TMEM30B","url":"https://depmap.org/portal/gene/TMEM30B","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CDC50B","total_profiled":1310},"omim":[{"mim_id":"611030","title":"TRANSMEMBRANE PROTEIN 30C; TMEM30C","url":"https://www.omim.org/entry/611030"},{"mim_id":"611029","title":"TRANSMEMBRANE PROTEIN 30B; TMEM30B","url":"https://www.omim.org/entry/611029"},{"mim_id":"611028","title":"TRANSMEMBRANE PROTEIN 30A; TMEM30A","url":"https://www.omim.org/entry/611028"}],"hpa":{"profiled":true,"resolved_as":"TMEM30B","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TMEM30B"},"hgnc":{"alias_symbol":[],"prev_symbol":["TMEM30B"]},"alphafold":{"accession":"Q3MIR4","domains":[{"cath_id":"-","chopping":"61-307","consensus_level":"medium","plddt":94.1833,"start":61,"end":307},{"cath_id":"1.10.287","chopping":"33-60_315-337","consensus_level":"medium","plddt":95.7802,"start":33,"end":337}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q3MIR4","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q3MIR4-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q3MIR4-F1-predicted_aligned_error_v6.png","plddt_mean":92.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CDC50B","jax_strain_url":"https://www.jax.org/strain/search?query=CDC50B"},"sequence":{"accession":"Q3MIR4","fasta_url":"https://rest.uniprot.org/uniprotkb/Q3MIR4.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q3MIR4/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q3MIR4"}},"corpus_meta":[{"pmid":"17948906","id":"PMC_17948906","title":"ATP8B1 requires an accessory protein for endoplasmic reticulum exit and plasma membrane lipid flippase activity.","date":"2008","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/17948906","citation_count":191,"is_preprint":false},{"pmid":"16778180","id":"PMC_16778180","title":"Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas.","date":"2006","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16778180","citation_count":150,"is_preprint":false},{"pmid":"21454556","id":"PMC_21454556","title":"Critical role of the beta-subunit CDC50A in the stable expression, assembly, subcellular localization, and lipid transport activity of the P4-ATPase ATP8A2.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21454556","citation_count":122,"is_preprint":false},{"pmid":"20947505","id":"PMC_20947505","title":"Heteromeric interactions required for abundance and subcellular localization of human CDC50 proteins and class 1 P4-ATPases.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20947505","citation_count":109,"is_preprint":false},{"pmid":"19887624","id":"PMC_19887624","title":"Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma.","date":"2009","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19887624","citation_count":98,"is_preprint":false},{"pmid":"26169495","id":"PMC_26169495","title":"Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors.","date":"2015","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26169495","citation_count":90,"is_preprint":false},{"pmid":"15375526","id":"PMC_15375526","title":"Identification and characterization of CDC50A, CDC50B and CDC50C genes in silico.","date":"2004","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/15375526","citation_count":56,"is_preprint":false},{"pmid":"20685720","id":"PMC_20685720","title":"Differential expression profiling analyses identifies downregulation of 1p, 6q, and 14q genes and overexpression of 6p histone cluster 1 genes as markers of recurrence in meningiomas.","date":"2010","source":"Neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/20685720","citation_count":48,"is_preprint":false},{"pmid":"22964784","id":"PMC_22964784","title":"Genetic alterations associated with progression and recurrence in meningiomas.","date":"2012","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/22964784","citation_count":43,"is_preprint":false},{"pmid":"35349344","id":"PMC_35349344","title":"Structural insights into the activation of autoinhibited human lipid flippase ATP8B1 upon substrate binding.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/35349344","citation_count":28,"is_preprint":false},{"pmid":"17258408","id":"PMC_17258408","title":"Aberrant termination of reproduction-related TMEM30C transcripts in the hominoids.","date":"2006","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/17258408","citation_count":15,"is_preprint":false},{"pmid":"35862778","id":"PMC_35862778","title":"CDC50 Orthologues in Plasmodium falciparum Have Distinct Roles in Merozoite Egress and Trophozoite Maturation.","date":"2022","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/35862778","citation_count":14,"is_preprint":false},{"pmid":"22836805","id":"PMC_22836805","title":"Characterization of DNA hypermethylation in two cases of peritoneal mesothelioma.","date":"2012","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22836805","citation_count":12,"is_preprint":false},{"pmid":"37293153","id":"PMC_37293153","title":"Structural, topological, and functional characterization of transmembrane proteins TMEM213, 207, 116, 72 and 30B provides a potential link to ccRCC etiology.","date":"2023","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/37293153","citation_count":9,"is_preprint":false},{"pmid":"39384739","id":"PMC_39384739","title":"CREB3L1 deficiency impairs odontoblastic differentiation and molar dentin deposition partially through the TMEM30B.","date":"2024","source":"International journal of oral science","url":"https://pubmed.ncbi.nlm.nih.gov/39384739","citation_count":2,"is_preprint":false},{"pmid":"42054370","id":"PMC_42054370","title":"Regulation of Tmem30b-mediated apical membrane homeostasis in auditory outer hair cells is critical for hearing.","date":"2026","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/42054370","citation_count":0,"is_preprint":false},{"pmid":"41726979","id":"PMC_41726979","title":"ATP8B1-TMEM30B Flippase Activity Maintains Stereocilia Lipid Asymmetry Required for Hearing.","date":"2026","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41726979","citation_count":0,"is_preprint":false},{"pmid":"42125792","id":"PMC_42125792","title":"Examining the role of lipids in hearing.","date":"2026","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/42125792","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":11851,"output_tokens":2492,"usd":0.036466,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9647,"output_tokens":2887,"usd":0.060205,"stage2_stop_reason":"end_turn"},"total_usd":0.096671,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2008,\n      \"finding\": \"CDC50B acts as an accessory protein required for ER exit and plasma membrane trafficking of the P4-ATPase ATP8B1; coexpression of CDC50B with ATP8B1 in CHO cells relocalizes ATP8B1 from the ER to the plasma membrane and increases fluorescently labeled phosphatidylserine translocation by 250–500%, while also reducing phosphatidylserine exposure on the outer leaflet of the plasma membrane by ~17–25%.\",\n      \"method\": \"Heterologous coexpression in CHO cells, fluorescent lipid translocation assay, annexin V-based phosphatidylserine exposure assay, subcellular localization imaging\",\n      \"journal\": \"Hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal functional rescue in cells with two orthogonal readouts (lipid translocation assay and PS-exposure assay), single lab but multiple methods\",\n      \"pmids\": [\"17948906\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"CDC50B interacts with (co-immunoprecipitates) the class 1 P4-ATPases ATP8B1 and ATP8B2 but not with ATP8B4, ATP8A1, or ATP8A2; CDC50B coexpression shifts ATP8B1 from the ER to the plasma membrane; interactions between CDC50 proteins and P4-ATPases are required for ER exit and stability of both subunits; subcellular localization of the complex is determined by the P4-ATPase subunit, not by CDC50B.\",\n      \"method\": \"Co-immunoprecipitation, subcellular localization imaging in heterologous expression system\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with multiple P4-ATPases tested for specificity, plus localization experiments, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"20947505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CDC50B does NOT associate with ATP8A2 in HEK293T cells and does not support phosphatidylserine flippase activity of ATP8A2; chimeric CDC50 proteins replacing domains of CDC50B with CDC50A domains showed that both transmembrane and exocytoplasmic domains of CDC50A (not CDC50B) are required for a functional ATP8A2 complex, indicating CDC50B is insufficient as a beta-subunit for ATP8A2.\",\n      \"method\": \"Co-immunoprecipitation in HEK293T cells, chimeric protein domain-swap mutagenesis, lipid transport assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — negative result for CDC50B–ATP8A2 interaction established by co-IP and confirmed by chimera mutagenesis plus functional lipid transport assay, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"21454556\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CDC50B (TMEM30B) was identified in silico as a two-transmembrane-spanning protein with one extracellular loop, conserved topology with yeast Cdc50p/Lem3p homologs, and predicted to function as a component of phospholipid translocators; mapped to human chromosome 14q23.1.\",\n      \"method\": \"Bioinformatics/in silico sequence and topology analysis\",\n      \"journal\": \"Oncology reports\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — computational prediction only, no experimental validation in this paper\",\n      \"pmids\": [\"15375526\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Cryo-EM structures of ATP8B1 complexed with both CDC50A and CDC50B reveal that CDC50B can serve as an auxiliary noncatalytic partner of ATP8B1 and that the complex adopts an autoinhibited state that is released upon substrate (phospholipid) binding; bile acids can facilitate release of this autoinhibition.\",\n      \"method\": \"Cryo-EM structure determination, substrate-binding analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — cryo-EM structural determination of the ATP8B1–CDC50B complex with mechanistic interpretation of autoinhibition release, single study but Tier 1 method\",\n      \"pmids\": [\"35349344\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Experimental validation in HEK293 and HK-2 cells confirmed that TMEM30B (CDC50B) is a membrane-bound protein localized to the endoplasmic reticulum, with both N- and C-termini facing the cytoplasm.\",\n      \"method\": \"Overexpression studies, subcellular fractionation, topology/localization assays in HEK293 and HK-2 cells\",\n      \"journal\": \"American journal of cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct localization experiment with topology determination, single lab, single study\",\n      \"pmids\": [\"37293153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TMEM30B is a direct transcriptional target of CREB3L1 in odontoblasts; deletion of Tmem30b in mouse dental papilla cells (mDPCs) impaired odontoblastic differentiation, protein synthesis, and protein secretion; overexpression of TMEM30B in CREB3L1-deficient mDPCs partially rescued extracellular protein secretion.\",\n      \"method\": \"ATAC-seq, RNA-seq, Tmem30b knockout in mDPCs, rescue by TMEM30B overexpression, in vivo Creb3l1 conditional knockout\",\n      \"journal\": \"International journal of oral science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with defined cellular phenotypes and partial rescue experiment, single lab with multiple orthogonal methods (ATAC-seq, RNA-seq, functional assays)\",\n      \"pmids\": [\"39384739\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"In cochlear outer hair cells (OHCs), Tmem30b partners with Atp8b1 to regulate phospholipid asymmetry; Tmem30b-/- mice show early-onset hearing loss with OHC stereocilia disorganization starting at P7 (coinciding with Tmem30b localization to stereocilia); AAV-mediated delivery of Tmem30b rescues stereocilia defects in both Tmem30b-/- and Atp8b1-/- mice; Tmem30b translocates from the nuclear membrane at P5 to stereocilia and cuticular plate during maturation.\",\n      \"method\": \"Tmem30b knockout mouse, live imaging/immunofluorescence for localization, AAV rescue experiment, auditory function testing (ABR), co-localization studies\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with defined phenotype, AAV rescue (including cross-rescue in Atp8b1-/- mice), dynamic localization tracking, multiple orthogonal methods in single study\",\n      \"pmids\": [\"42054370\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"ATP8B1 and TMEM30B are selectively expressed in OHCs, enriched in stereocilia, and upregulated following onset of mechanoelectrical transduction (MET) and hearing; loss of TMEM30B results in elevated ABR thresholds, phosphatidylserine externalization, and rapid hair-cell degeneration, establishing TMEM30B as required for membrane lipid asymmetry maintenance in OHCs.\",\n      \"method\": \"Conditional knockout mouse, auditory brainstem response (ABR) measurement, immunofluorescence/localization, phosphatidylserine externalization assay\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — preprint, loss-of-function with multiple functional readouts, single lab\",\n      \"pmids\": [\"41726979\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"CDC50B (TMEM30B) is a two-transmembrane ER-resident chaperone/beta-subunit that physically associates with select class 1 P4-ATPases (notably ATP8B1 and ATP8B2 but not ATP8A2), facilitating their ER exit, trafficking to the plasma membrane, and phosphatidylserine flippase activity; cryo-EM structures show CDC50B binds ATP8B1 as a noncatalytic auxiliary subunit stabilizing an autoinhibited state that is released upon lipid substrate binding; in cochlear outer hair cells, the Tmem30b–Atp8b1 complex localizes to stereocilia and the cuticular plate to maintain phospholipid asymmetry, and its loss causes stereocilia disorganization and hearing loss; CDC50B also plays a role in protein secretion during odontoblast differentiation downstream of CREB3L1.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CDC50B (TMEM30B) is a two-transmembrane, endoplasmic reticulum-resident accessory subunit that selectively partners with class 1 P4-ATPase phospholipid flippases to enforce membrane lipid asymmetry [#0, #1, #5]. It physically associates with ATP8B1 and ATP8B2 — but not ATP8B4, ATP8A1, or ATP8A2 — and this interaction is mutually required for ER exit and stability of both partners, with the P4-ATPase subunit dictating the final localization of the complex [#1]. Functionally, CDC50B coexpression relocalizes ATP8B1 from the ER to the plasma membrane and markedly increases inward phosphatidylserine translocation while reducing outer-leaflet PS exposure [#0]. Cryo-EM of the ATP8B1–CDC50B complex shows CDC50B serving as a noncatalytic auxiliary partner that stabilizes an autoinhibited state released upon phospholipid substrate binding, with bile acids facilitating this release [#4]. The complex has a defined physiological role in cochlear outer hair cells, where the Tmem30b–Atp8b1 pair localizes to stereocilia and the cuticular plate to maintain phospholipid asymmetry; loss of Tmem30b causes phosphatidylserine externalization, stereocilia disorganization, hair-cell degeneration, and early-onset hearing loss that is reversible by AAV-mediated Tmem30b delivery [#7]. Beyond its flippase chaperone role, CDC50B is a direct transcriptional target of CREB3L1 and supports protein synthesis and secretion during odontoblast differentiation [#6].\",\n  \"teleology\": [\n    {\n      \"year\": 2008,\n      \"claim\": \"Established that CDC50B is not merely a sequence homolog but a functional accessory protein that traffics a P4-ATPase out of the ER and enables its flippase activity, defining its core role.\",\n      \"evidence\": \"Heterologous coexpression in CHO cells with fluorescent lipid translocation and annexin V PS-exposure assays\",\n      \"pmids\": [\"17948906\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not test specificity against other P4-ATPases\", \"Mechanism of how CDC50B promotes ER exit not resolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defined the partner selectivity and mutual dependence of the interaction, showing CDC50B binds ATP8B1/ATP8B2 specifically and that the P4-ATPase, not CDC50B, sets complex localization.\",\n      \"evidence\": \"Co-IP with a panel of P4-ATPases and subcellular localization imaging in heterologous cells\",\n      \"pmids\": [\"20947505\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish stoichiometry or structural basis of selectivity\", \"Endogenous interactions not confirmed\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Delimited CDC50B function by showing it is insufficient as a beta-subunit for ATP8A2, with chimera swaps pinpointing CDC50A's transmembrane and exocytoplasmic domains as the determinants of that incompatibility.\",\n      \"evidence\": \"Co-IP and chimeric domain-swap mutagenesis with lipid transport assay in HEK293T cells\",\n      \"pmids\": [\"21454556\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why CDC50B cannot substitute structurally remained undefined at the time\", \"Did not address physiological tissue-specific pairing\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Provided structural mechanism, showing CDC50B acts as a noncatalytic auxiliary subunit stabilizing an autoinhibited ATP8B1 state that is relieved by substrate and bile acids.\",\n      \"evidence\": \"Cryo-EM structure determination of ATP8B1 with CDC50A and CDC50B plus substrate-binding analysis\",\n      \"pmids\": [\"35349344\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of autoinhibition release in cells not quantified\", \"Whether CDC50B vs CDC50A confer distinct regulatory properties not resolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Confirmed CDC50B is an ER-localized membrane protein with both termini cytoplasmic, anchoring its topology and subcellular compartment experimentally.\",\n      \"evidence\": \"Overexpression, subcellular fractionation, and topology assays in HEK293 and HK-2 cells\",\n      \"pmids\": [\"37293153\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab topology determination\", \"ER residence under endogenous conditions not shown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Extended CDC50B function beyond flippase chaperoning by placing it in a CREB3L1 secretory program, where it supports protein synthesis and secretion during odontoblast differentiation.\",\n      \"evidence\": \"ATAC-seq, RNA-seq, Tmem30b knockout in mDPCs, and overexpression rescue in CREB3L1-deficient cells\",\n      \"pmids\": [\"39384739\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular link between flippase activity and secretion not established\", \"Rescue was only partial\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Demonstrated an in vivo physiological requirement: the Tmem30b–Atp8b1 complex maintains stereocilia lipid asymmetry, and its loss causes hearing loss rescuable by gene delivery, including cross-rescue of Atp8b1 mutants.\",\n      \"evidence\": \"Tmem30b knockout mice, dynamic localization imaging, AAV rescue, and ABR auditory testing\",\n      \"pmids\": [\"42054370\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking lipid asymmetry loss to stereocilia disorganization not detailed\", \"Relevance to human hearing loss not directly tested\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Reinforced the OHC role by tying TMEM30B/ATP8B1 expression to mechanoelectrical transduction onset and showing loss causes PS externalization and rapid hair-cell degeneration.\",\n      \"evidence\": \"Conditional knockout mice, ABR, immunofluorescence, and PS-externalization assays (preprint)\",\n      \"pmids\": [\"41726979\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint, not peer-reviewed\", \"Overlaps with the same year's published study; independent confirmation pending\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How CDC50B selectivity for ATP8B1/ATP8B2, its ER-exit chaperone role, and its CREB3L1-linked secretory function are mechanistically integrated, and whether human CDC50B mutations cause disease, remain open.\",\n      \"evidence\": null,\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No human disease-causing mutation reported in the corpus\", \"Connection between flippase activity and protein secretion unresolved\", \"Tissue-specific partner choice mechanism unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 4]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [0, 1, 5]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1, 7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": []}\n    ],\n    \"complexes\": [\"ATP8B1\\u2013CDC50B P4-ATPase flippase complex\"],\n    \"partners\": [\"ATP8B1\", \"ATP8B2\", \"CREB3L1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":6,"faith_pct":83.33333333333333}}